Latest minority interest for GSK: $-470M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), GSK shows a minority interest of $-470M. That compares with $-440M in the prior-year period — down 6.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, GSK's minority interest is now $-470M (was $-440M) — a 6.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GSK Plc is outperforming or lagging.
Tracking GSK's minority interest over time shows whether GSK Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $-470M That compares with $-440M in the prior-year period — down 6.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this minority interest page, Stockcircle has GSK Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $-470M) with ownership activity and broader fundamentals.
GSK Plc's minority interest is $-470M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.